Awarded contract
Nicotine Replacement Therapy Products
Details
- Supplier(s)
- Glaxosmithkline Consumer Healthcare
- Value
- GBP 3,142,684
- Topic
- Pharmaceutical products
- Published
- 20 November 2020
Tender description
Supply of Nicotine Replacement Therapy Products in the form of patches, gum and lozenges to NHS Scotland. The Framework Agreement will cover supply in primary and secondary care settings as well as to Prisons across Scotland.
Timeline
- Completed: Award date27 October 2020
- Completed: Award published20 November 2020Current notice
About the buyer
NHS National Services Scotland is a public sector buyer in United Kingdom publishing tenders and awards on Stotles. Explore their procurement activity and find more opportunities like this one.
Relevant CPV codes
- 33600000 · Pharmaceutical products
Decision makers
Connect with the people behind this procurement.
| Contact name | Job title | Phone number | Work email |
|---|---|---|---|
| Head of Procurement | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Commercial Director | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Procurement Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Category Lead | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Senior Buyer | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov | |
| Contracts Manager | +44 •••• •••••• | ••••••••@nhs-national-services-scotland.gov |
6 similar open tenders
See more open tenders related to Nicotine Replacement Therapy Products.
- Open tender
IMP Manufacture, Labelling and Packaging DPS
- Open tender
CPH037 - Enhanced Services (Pharmacies)
- Open tender
Potassium iodide tablets 2024-2026
Related buyers
Buyers similar to NHS National Services Scotland.
BuyersCountValue
- 19£4.6m
- 9£1.1m
- 6£445.5k
- 4£964.7k
- 2£252.0k
- 1£4.4m
- 742£1.9bn
- 231£2.0bn
- 136£1.4bn
- 122£59.9m
Win more public sector contracts
Track every UK and Ireland tender in one place — set up alerts, find decision-makers, and never miss an opportunity.
